UBS Group
OXFD

UBS Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

UBS Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-472
Closed -$6K – 9049
2020
Q3 		$6K Buy
+472
New +$6.26K ﹤0.01% 7266
2020
Q2 		– Sell
-145
Closed -$1K – 8603
2020
Q1 		$1K Sell
145
-186
-56% -$2.6K ﹤0.01% 7875
2019
Q4 		$5K Sell
331
-1,245
-79% -$20.2K ﹤0.01% 7617
2019
Q3 		$26K Sell
1,576
-902
-36% -$12.5K ﹤0.01% 6594
2019
Q2 		$34K Buy
+2,478
New +$37.9K ﹤0.01% 6245
2019
Q1 		– Sell
-10,557
Closed -$135K – 8406
2018
Q4 		$135K Buy
10,557
+4,342
+70% +$65.9K ﹤0.01% 5284
2018
Q3 		$101K Buy
6,215
+2,785
+81% +$39.8K ﹤0.01% 5598
2018
Q2 		$44K Buy
3,430
+2,469
+257% +$33.4K ﹤0.01% 6087
2018
Q1 		$12K Sell
961
-284
-23% -$3.46K ﹤0.01% 6782
2017
Q4 		$17K Sell
1,245
-478
-28% -$7K ﹤0.01% 6694
2017
Q3 		$29K Buy
1,723
+1,573
+1,049% +$25.6K ﹤0.01% 6194
2017
Q2 		$3K Sell
150
-1,697
-92% -$25.4K ﹤0.01% 7322
2017
Q1 		$29K Sell
1,847
-2,331
-56% -$33.3K ﹤0.01% 5892
2016
Q4 		$62K Buy
4,178
+3,284
+367% +$46.1K ﹤0.01% 5657
2016
Q3 		$11K Buy
+894
New +$8.97K ﹤0.01% 6742
2016
Q1 		– Sell
-2,520
Closed -$29K – 8422
2015
Q4 		$29K Buy
2,520
+1,730
+219% +$21.4K ﹤0.01% 6378
2015
Q3 		$11K Sell
790
-126
-14% -$1.71K ﹤0.01% 7219
2015
Q2 		$13K Buy
+916
New +$12.4K ﹤0.01% 7276
2015
Q1 		– Sell
-556
Closed -$8K – 9624
2014
Q4 		$8K Buy
+556
New +$7.6K ﹤0.01% 8633

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group's OXFD Position: Q4 2020 in Review

UBS Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 472 shares — an estimated $6K sold.

UBS Group first reported a position in OXFD in Q4 2014 and held it in 19 quarters. The position peaked at $135K in Q4 2018. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • UBS Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • UBS Group sold 472 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $6K.
  • UBS Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2014 and held it in 19 quarters.
  • UBS Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $135K in Q4 2018.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.